A rare case of Ewing's sarcoma of the maxillary sinus.
Diagnosis
Ewing's sarcoma
Imaging
Maxillary sinus
Oncology
Journal
Radiology case reports
ISSN: 1930-0433
Titre abrégé: Radiol Case Rep
Pays: Netherlands
ID NLM: 101467888
Informations de publication
Date de publication:
Dec 2023
Dec 2023
Historique:
received:
13
07
2023
revised:
15
08
2023
accepted:
21
08
2023
medline:
28
9
2023
pubmed:
28
9
2023
entrez:
28
9
2023
Statut:
epublish
Résumé
Ewing's sarcoma is generally an aggressive, poorly differentiated bone and soft tissue tumor affecting children and young adults, it accounts for 4%-6% of all primary bone tumors and primary facial locations occur in only 1%-4% of all cases, primarily in the mandible and calvaria. Involvement of the paranasal sinuses is rare. Here we report the case of an 11-year-old girl with no medical, surgical, or traumatic history, who presented for 1 month and progressive evolution of swelling of the left cheek, associated with pain, nasal obstruction, rhinorrhea, and a slight weight loss not quantified. A craniofacial computed tomography (CT) scan showed a mixed lytic and condensing lesional tissue process centered on the left maxillary sinus, heterogeneously enhanced after contrast injection, lysing the walls of the sinus extended to the homolateral nasal cavity and slightly infiltrating the adjacent soft tissues. An incisional biopsy was performed and the pathological study proved that it was Ewing's sarcoma. She was put on neoadjuvant chemotherapy using 6 courses of vincristine, doxorubicin, ifosfamide, etoposide which resulted in a partial regression of the tumor size by 50%. Then the patient was put on combined chemotherapy and radiotherapy. A follow-up CT scan after 6 courses of vincristine, actinomycin, cyclophosphamide, and 17 sessions of radiotherapy showed lesion stability. Maxillary Ewing's sarcoma is a rare and aggressive tumor. Therefore, early diagnosis, combination therapy, and long-term follow-up are suggested in such cases to improve the survival rate.
Identifiants
pubmed: 37766835
doi: 10.1016/j.radcr.2023.08.095
pii: S1930-0433(23)00616-7
pmc: PMC10520663
doi:
Types de publication
Case Reports
Langues
eng
Pagination
4248-4252Informations de copyright
© 2023 The Authors. Published by Elsevier Inc. on behalf of University of Washington.
Références
Head Neck Pathol. 2011 Mar;5(1):8-16
pubmed: 21107767
Int J Clin Exp Pathol. 2015 Jan 01;8(1):960-6
pubmed: 25755803
J Clin Oncol. 2000 Sep;18(17):3108-14
pubmed: 10963639
N Engl J Med. 2003 Feb 20;348(8):694-701
pubmed: 12594313
Cancer. 2007 Feb 15;109(4):767-75
pubmed: 17238190
J Clin Oncol. 2009 May 20;27(15):2536-41
pubmed: 19349548
J Oral Maxillofac Surg. 2005 Oct;63(10):1539-42
pubmed: 16182926
Auris Nasus Larynx. 2011 Aug;38(4):480-6
pubmed: 21227608
J Oral Sci. 2007 Jun;49(2):167-71
pubmed: 17634731
Am J Clin Oncol. 2010 Aug;33(4):321-6
pubmed: 19841575
Skull Base. 2009 Nov;19(6):409-16
pubmed: 20436842
J Cancer Res Ther. 2012 Jan-Mar;8(1):142-4
pubmed: 22531536
Hematol Oncol Clin North Am. 2005 Jun;19(3):501-25, vi-vii
pubmed: 15939194